Sunday, December 10, 2006

Biomet: An Acquisition Target?

News sources are reporting Biomet (BMET) , a dividend growth stock, may be acquired by Smith & Nephew Plc. in a transaction valued at $11 billion. Smith & Nephew trades as an ADR under the symbol SNN.

(click on graph for larger image)

Biomet has a 5-year historical dividend growth rate of 30%. The company's last increase in September was 20% higher than the same period last year. The company pays one dividend per year in the 3rd quarter. The stock yields .8% and maintains an S&P Earnings and Dividend Ranking of A.

No comments :